Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance

Go back to Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance
(NASDAQ: TARS) Delayed: 63.16 +0.61 (0.98%)
Previous Close $62.55    52 Week High
Open $63.38    52 Week Low
Day High $64.24    P/E N/A 
Day Low $62.37    EPS
Volume 402,143